John Gandolfo Re:Addendum to Executive Employment Agreement Dear Mr. Gandolfo:Executive Employment Agreement • March 30th, 2022 • Eyenovia, Inc. • Pharmaceutical preparations
Contract Type FiledMarch 30th, 2022 Company IndustryThe following Addendum represents a modification to the Executive Employment Agreement dated February 15, 2019 (the “Agreement”) between Eyenovia, Inc., a Delaware corporation (the “Company”), and John Gandolfo (the “Executive”) for the express purpose of modifying the terms contained in the Agreement between the parties with respect to the matters below. To the extent that there is an inconsistency between the terms of this Addendum and the terms of the Agreement, the terms of this Addendum shall control. The Agreement is hereby modified, amended or superseded to the extent indicated:
Michael M. Rowe Re:Addendum to Executive Employment Agreement Dear Mr. Rowe:Executive Employment Agreement • March 30th, 2022 • Eyenovia, Inc. • Pharmaceutical preparations
Contract Type FiledMarch 30th, 2022 Company IndustryThe following Addendum represents a modification to the Executive Employment Agreement dated February 15, 2019 (the “Agreement”) between Eyenovia, Inc., a Delaware corporation (the “Company”), and Michael M. Rowe (the “Executive”) for the express purpose of modifying the terms contained in the Agreement between the parties with respect to the matters below. To the extent that there is an inconsistency between the terms of this Addendum and the terms of the Agreement, the terms of this Addendum shall control. The Agreement is hereby modified, amended or superseded to the extent indicated:
Tsontcho Ianchulev, M.D., M.P.H. Re:Addendum to Executive Employment Agreement Dear Dr. Ianchulev:Executive Employment Agreement • March 30th, 2022 • Eyenovia, Inc. • Pharmaceutical preparations
Contract Type FiledMarch 30th, 2022 Company IndustryThe following Addendum represents a modification to the Executive Employment Agreement dated February 15, 2019 (the “Agreement”) between Eyenovia, Inc., a Delaware corporation (the “Company”), and Tsontcho Ianchulev (the “Executive”) for the express purpose of modifying the terms contained in the Agreement between the parties with respect to the matters below. To the extent that there is an inconsistency between the terms of this Addendum and the terms of the Agreement, the terms of this Addendum shall control. The Agreement is hereby modified, amended or superseded to the extent indicated: